BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16737439)

  • 1. [Spinal involvement as first presentation of Hodgkin's disease].
    Navarro Calzada J; Cuesta Muñoz J; Crusells Canales MJ; Letona Carbajo S; Sanjoaquín Conde I; Amiguet García JA
    An Med Interna; 2006 Mar; 23(3):142-3. PubMed ID: 16737439
    [No Abstract]   [Full Text] [Related]  

  • 2. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
    Jost LM; Stahel RA;
    Ann Oncol; 2005; 16 Suppl 1():i54-5. PubMed ID: 15888755
    [No Abstract]   [Full Text] [Related]  

  • 3. Presentation of Hodgkin's lymphoma with Ophelia syndrome.
    Olmos D; Rueda A; Jurado JM; Alba E
    J Clin Oncol; 2007 May; 25(13):1802-3. PubMed ID: 17470872
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual presentation of Hodgkin's lymphoma.
    Knibbeler-van Rossum CT; Peters FJ; Erdkamp FL; Bos LP
    Ann Oncol; 2002 Apr; 13(4):637-8. PubMed ID: 12056718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary pulmonary Hodgkin's disease].
    Hosoi K; Chikuie N; Min KY; Satoh T; Tokumine Y; Ishikawa K; Maeda H; Ueda K; Inoue M
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1399-401. PubMed ID: 16097597
    [No Abstract]   [Full Text] [Related]  

  • 6. Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor.
    Gastaldi R; Martino P; Gentile G; Picardi V; De Propris MS; Pirillo MF; De Vellis A; Mandelli F
    Ann Oncol; 2002 Jul; 13(7):1158-60. PubMed ID: 12176798
    [No Abstract]   [Full Text] [Related]  

  • 7. Hodgkin's disease presenting with osseous involvement.
    Chandra D; Ewton A; Baker K
    Am J Hematol; 2006 Jul; 81(7):550-1. PubMed ID: 16755566
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
    Basaran G; Agaoglu F; Basaran M
    J Clin Oncol; 2010 Sep; 28(27):e485-6; author reply e487. PubMed ID: 20606082
    [No Abstract]   [Full Text] [Related]  

  • 9. Hodgkin Lymphoma Presentation With Extensive Chest Wall Muscle Involvement in an Adult.
    Gorospe L; Chinea-Rodríguez A; García-Cosío-Piqueras M; Calbacho-Robles M; Almeida-Aróstegui NA
    Ann Thorac Surg; 2018 Jul; 106(1):e37. PubMed ID: 29452117
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary cutaneous Hodgkin's lymphoma.
    Mukesh M; Shuttleworth D; Murray P
    Clin Exp Dermatol; 2009 Dec; 34(8):e673-5. PubMed ID: 19817768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation.
    Simpson L; Taylor S; Piotrowski A
    J Clin Oncol; 2004 Jan; 22(1):196-8. PubMed ID: 14701784
    [No Abstract]   [Full Text] [Related]  

  • 12. Pericardial effusion due to pericardium involvement by Hodgkin's lymphoma.
    Guastafierro S; Cappabianca S; Falcone U
    Ann Hematol; 2013 Jun; 92(6):853-4. PubMed ID: 23196418
    [No Abstract]   [Full Text] [Related]  

  • 13. Masked Hodgkin's disease: the pruriginous disguise.
    Stefanato CM; Reyes-Mugica M
    Pediatr Hematol Oncol; 1996; 13(3):293-4. PubMed ID: 8735347
    [No Abstract]   [Full Text] [Related]  

  • 14. Hodgkin's lymphoma: better outcomes with fewer drugs?
    Casasnovas O; Coiffier B
    Lancet; 2015 Apr; 385(9976):1371-3. PubMed ID: 25539731
    [No Abstract]   [Full Text] [Related]  

  • 15. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
    Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
    Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniofacial fibrous dysplasia and hypophysial microadenoma with Hodgkin's lymphoma: unusual involution of an extensive case.
    Varol A; Basa S; Seçkinel SA; Argon D; Tecimer T
    J Oral Maxillofac Surg; 2006 Aug; 64(8):1283-8. PubMed ID: 16860225
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
    Johnson PW; Radford JA; Cullen MH; Sydes MR; Stenning SP; Hancock BW
    J Clin Oncol; 2006 Jul; 24(20):3309; author reply 3309-10. PubMed ID: 16829655
    [No Abstract]   [Full Text] [Related]  

  • 18. Communication challenges in a young man with Hodgkin's disease.
    Medoff E
    Cancer Pract; 2001; 9(6):272-6. PubMed ID: 11879328
    [No Abstract]   [Full Text] [Related]  

  • 19. Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission.
    Sánchez M; Enríquez R; Sirvent AE; Heredia L; Millán I; Amorós F
    Nefrologia; 2013; 33(5):745-7. PubMed ID: 24089174
    [No Abstract]   [Full Text] [Related]  

  • 20. Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy.
    Specht L
    Cancer Treat Rev; 2004 Aug; 30(5):479-82. PubMed ID: 15245780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.